On Friday, Neumora Therapeutics Inc (NASDAQ: NMRA) was -7.26% drop from the session before settling in for the closing price of $1.79. A 52-week range for NMRA has been $0.61 – $3.25.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -586.93%. When this article was written, the company’s average yearly earnings per share was at 6.64%. With a float of $57.94 million, this company’s outstanding shares have now reached $161.95 million.
Neumora Therapeutics Inc (NMRA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Neumora Therapeutics Inc stocks. The insider ownership of Neumora Therapeutics Inc is 65.32%, while institutional ownership is 18.65%. The most recent insider transaction that took place on Nov 11 ’25, was worth 307,026. In this transaction an insider of this company sold 114,703 shares at a rate of $2.68, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 11 ’25, when Company’s Director proposed sale 114,703 for $2.68, making the entire transaction worth $307,027.
Neumora Therapeutics Inc (NMRA) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.37 earnings per share (EPS) during the time that was better than consensus figure (set at -0.44) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.90% during the next five years compared to -586.93% drop over the previous five years of trading.
Neumora Therapeutics Inc (NASDAQ: NMRA) Trading Performance Indicators
You can see what Neumora Therapeutics Inc (NMRA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Neumora Therapeutics Inc (NMRA)
As of the previous 9 days, the stock’s Stochastic %D was 38.31%.
During the past 100 days, Neumora Therapeutics Inc’s (NMRA) raw stochastic average was set at 14.52%, which indicates a significant decrease from 16.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1232 in the past 14 days, which was lower than the 0.1615 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2850, while its 200-day Moving Average is $1.5114. Now, the first resistance to watch is $1.7996. This is followed by the second major resistance level at $1.9392. The third major resistance level sits at $2.0540. If the price goes on to break the first support level at $1.5452, it is likely to go to the next support level at $1.4304. The third support level lies at $1.2908 if the price breaches the second support level.
Neumora Therapeutics Inc (NASDAQ: NMRA) Key Stats
There are 167,089K outstanding shares of the company, which has a market capitalization of 277.37 million. As of now, sales total 0 K while income totals -243,790 K. Its latest quarter income was 0 K while its last quarter net income were -56,760 K.
